Age, years; median (90% range) |
52 (19–75) |
58 |
42 (16–71) |
45 |
0.107 |
Sex, male (%) |
36 (62) |
58 |
33 (73) |
45 |
0.228 |
Duration of illness, days; median (90% range) |
15 (4–120) |
58 |
3 (1–26) |
45 |
0.0001 |
Duration of headache, days; median (90% range) |
7 (0–50) |
58 |
2 (0–26) |
45 |
0.178 |
Duration of fever, days; median (90% range) |
10 (0–63) |
58 |
2 (0–14) |
45 |
0.0001 |
Coma before admission (%) |
17 (29) |
58 |
14 (31) |
45 |
0.843 |
Hemiplegia (%) |
8 (14) |
58 |
4 (9) |
45 |
0.442 |
Cranial nerve palsies (%) |
7 (12) |
58 |
7 (16) |
45 |
0.609 |
Recent loss of weight (%) |
8 (14) |
58 |
1 (2) |
45 |
0.087 |
Night sweats (%) |
6 (10) |
58 |
0 (0) |
45 |
0.072 |
Coughing for 2 or more weeks (%) |
15 (26) |
58 |
1 (2) |
45 |
0.001 |
GCS; median (90% range) |
15 (9–15) |
58 |
15 (6–15) |
45 |
0.195 |
Meningeal signs (%) |
42 (72) |
58 |
43 (96) |
45 |
0.002 |
HCT %; median (90% range) |
35 (26–43) |
58 |
39 (22–49) |
45 |
0.005 |
Blood WCC (103/mL); median (90% range) |
7,700 (3,385–15,735) |
58 |
13,000 (5,300–30,480) |
45 |
0.0001 |
Blood % neutrophils; median (90% range) |
81 (50–95) |
58 |
89 (71–97) |
45 |
0.0001 |
Blood sodium, mmol/L; median (90% range) |
133 (120–142) |
58 |
138 (134–143) |
45 |
0.0001 |
CSF opening pressure, cm H20; median (90% range) |
18 (8–40) |
56 |
20 (9–34) |
45 |
0.559 |
Clear CSF appearance (%) |
51 (91) |
56 |
26 (58) |
45 |
0.0001 |
CSF total WCC (103/mL); median (90% range) |
40 (2–448) |
56 |
350 (7–4,852) |
45 |
0.0001 |
CSF % neutrophils; median (90% range) |
34 (0–75) |
54 |
80 (15–94) |
45 |
0.0001 |
CSF % lymphocytes; median (90% range) |
60 (18–95) |
54 |
20 (4–82) |
45 |
0.0001 |
CSF protein, g/dL; median (90% range) |
1,274 (214–2,810) |
56 |
1,350 (584–3,388) |
45 |
0.163 |
CSF/blood glucose; median (90% range) |
0.3 (0.12–0.7) |
56 |
0.25 (0.02–0.9) |
45 |
0.129 |
CSF chloride, mmol/L; median (90% range) |
115 (98–130) |
56 |
118 (107–129) |
45 |
0.023 |